Literature DB >> 2299487

Coronary arteriosclerosis in pediatric heart transplant survivors: limitation of long-term survival.

E Pahl1, F J Fricker, J Armitage, B P Griffith, S Taylor, B F Uretsky, L B Beerman, J R Zuberbuhler.   

Abstract

Because coronary atherosclerosis after heart transplantation has been a limiting problem in long-term survival of adults, we reviewed the coronary angiograms, and autopsy data when available, from 21 of 30 children who underwent orthotopic heart transplantation and survived the perioperative period. Six patients had coronary atherosclerosis, and five of these patients died 6 months to 3 years after heart transplantation. The late deaths were sudden and unexpected. Coronary angiography demonstrated several types of lesions, including concentric narrowing, tubular segmental lesions, and abrupt obliteration of major coronary vessels. Risk factors assessed included hypertension, hyperlipidemia, cytomegalovirus infection, type of immunosuppressive regimen, number of rejection episodes, and major histocompatibility antigen mismatches. Only the frequency and duration of rejection episodes seemed to be more prevalent in the patients in whom coronary atherosclerosis developed. Despite the benefits of heart transplantation in treating children with end-stage heart disease, coronary atherosclerosis may limit long-term survival. We suggest that these children should undergo serial coronary angiography to identify those at risk for subsequent events related to coronary artery disease.

Entities:  

Mesh:

Year:  1990        PMID: 2299487     DOI: 10.1016/s0022-3476(05)82871-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  13 in total

1.  Pediatric heart and lung transplantation.

Authors:  Subash C Reddy; Steven A Webber
Journal:  Indian J Pediatr       Date:  2003-09       Impact factor: 1.967

2.  Heart transplantation in children.

Authors:  D P Taggart; J H Dark
Journal:  BMJ       Date:  1991-05-04

Review 3.  VLA-4 and lymphocyte trafficking in immune-inflammatory states: novel therapeutic approaches in allograft arteriopathy.

Authors:  S Molossi; M Rabinovitch
Journal:  Springer Semin Immunopathol       Date:  1995

4.  Effects of pentoxifylline (Trental) on blood flow, viscosity, and oxygen transport in young adults with inoperable cyanotic congenital heart disease.

Authors:  W Berman; N Berman; D Pathak; S C Wood
Journal:  Pediatr Cardiol       Date:  1994 Mar-Apr       Impact factor: 1.655

5.  Identification of coronary artery disease in the pediatric cardiac transplant patient.

Authors:  Jacqueline Maiers; Roger Hurwitz
Journal:  Pediatr Cardiol       Date:  2007-09-21       Impact factor: 1.655

6.  Heart transplantation in children: mid-term results and quality of life.

Authors:  J LeBidois; J Kachaner; P Vouhé; D Sidi; D Tamisier
Journal:  Eur J Pediatr       Date:  1992       Impact factor: 3.183

7.  Heart transplantation for dilated cardiomyopathy.

Authors:  S S Adwani; B F Whitehead; P G Rees; P Whitmore; J W Fabre; M J Elliott; M R de Leval
Journal:  Arch Dis Child       Date:  1995-11       Impact factor: 3.791

8.  Longitudinal Strain and Strain Rate Abnormalities Precede Invasive Diagnosis of Transplant Coronary Artery Vasculopathy in Pediatric Cardiac Transplant Patients.

Authors:  Bridget B Zoeller; Shelley D Miyamoto; Adel K Younoszai; Bruce F Landeck
Journal:  Pediatr Cardiol       Date:  2016-01-27       Impact factor: 1.655

9.  Paediatric cardiac transplantation with steroid-sparing maintenance immunosuppression.

Authors:  J Au; J W Gregory; I W Colquhoun; C D Scott; C J Hilton; S Hunter; J H Dark
Journal:  Arch Dis Child       Date:  1992-10       Impact factor: 3.791

10.  Infrequency of cytomegalovirus genome in coronary arteriopathy of human heart allografts.

Authors:  J M Gulizia; R Kandolf; T J Kendall; S L Thieszen; J E Wilson; S J Radio; M R Costanzo; G L Winters; L L Miller; B M McManus
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.